Shares of Tyme Technologies Inc (NASDAQ:TYME) saw unusually-strong trading volume on Wednesday . Approximately 55,140 shares changed hands during trading, a decline of 95% from the previous session’s volume of 1,171,674 shares.The stock last traded at $3.60 and had previously closed at $3.60.
Several equities analysts recently weighed in on TYME shares. BidaskClub raised shares of Tyme Technologies from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 27th. Zacks Investment Research lowered shares of Tyme Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, January 10th. Finally, HC Wainwright reissued a “buy” rating and issued a $9.50 price target on shares of Tyme Technologies in a research report on Thursday, October 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. Tyme Technologies presently has a consensus rating of “Hold” and a consensus price target of $7.58.
The company has a market capitalization of $253.85 million, a PE ratio of -16.71 and a beta of 0.80.
Institutional investors have recently made changes to their positions in the company. Schwab Charles Investment Management Inc. acquired a new stake in Tyme Technologies during the second quarter worth $248,000. Northern Trust Corp acquired a new stake in Tyme Technologies during the second quarter worth $1,181,000. Rhumbline Advisers acquired a new stake in Tyme Technologies during the second quarter worth $110,000. BlackRock Inc. acquired a new stake in Tyme Technologies during the second quarter worth $6,303,000. Finally, Bank of New York Mellon Corp acquired a new stake in Tyme Technologies during the second quarter worth $267,000. Institutional investors and hedge funds own 11.26% of the company’s stock.
WARNING: “Tyme Technologies (TYME) Sees Unusually-High Trading Volume” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/4081056/tyme-technologies-tyme-sees-unusually-high-trading-volume.html.
Tyme Technologies Company Profile (NASDAQ:TYME)
Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.
Recommended Story: Trading Strategy
Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.